Key result
Complete revascularization during first angioplasty is linked to lower death, MI, and CABG versus incomplete revascularization.
Why the study?
Does complete revascularization via first PTCA improve long-term clinical outcomes compared to incomplete revascularization or failed PTCA?
Population
1390 patients undergoing a first PTCA without prior CABG, left main, or minimal vessel disease
Comparison
Complete revascularization (COREV) vs incomplete revascularization (INCOREV) or failed PTCA
Design
Multicentre registry cohort study
Follow-up
Mean 5.9 years (range 0-9.0 years)
Authors
Loading...
Early PTCA registry outcomes benchmark historical success; leaves open comparative durability versus modern revascularization strategies.
Cohort (n=1,390)
Yes
Does complete revascularization via first PTCA improve long-term clinical outcomes compared to incomplete revascularization or failed PTCA?
Complete revascularization during first PTCA is associated with lower rates of long-term mortality, MI, and CABG compared to incomplete revascularization or failed PTCA.
Bourassa et al. (1989) conducted a cohort in Coronary artery disease (n=1,390). Complete revascularization (COREV) vs. Incomplete revascularization (INCOREV) or failed PTCA was evaluated on In-hospital and long-term events (death, MI, CABG, repeat PTCA). Complete revascularization during a first coronary angioplasty was associated with significantly lower rates of in-hospital and long-term death, MI, and CABG compared to incomplete revascularization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: